mAb Production Modeling and Design Space Evaluation Including Glycosylation Process
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Due to high demand, monoclonal antibodies (mAbs) production needs to be efficient, as well as maintaining a high product quality. Quality by design (QbD) via predictive process modeling greatly facilitates process understanding and can be used to adjust process parameters to further improve the unit operations. In this work, mechanistic and dynamic kriging models are developed to capture the protein productivity and glycan fractions under different temperatures and pH levels. The design of experiments is used to generate input and output data for model training. The dynamic kriging model shows good performance in capturing the dynamic profiles of cell cultures and glycosylation using only limited input data. The developed model is further used for feasibility analysis, and successfully identifies the operating design space, maintaining high productivity and guaranteed product quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lowering culture temperature can decrease cell metabolism, cell proliferation, and expression of nucleotide sugar donor transporters and glycosyltransferases.38,40,42”
From Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis (2026) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and Analysis of Computer Experiments
Sacks, J., Welch, W. J., Mitchell, T. J., & Wynn, H. P. (1989) · Statistical Science · doi:10.1214/ss/1177012413 · Cited by 6,919
Advances in surrogate based modeling, feasibility analysis, and optimization: A review
Bhosekar, A., & Ierapetritou, M. (2018) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2017.09.017 · Cited by 707 · cited 3×
“where R is the correlation function and exponential, linear and squared exponential models are commonly used in kriging surrogates [28], shown in Equations (9)–(11).”
BackgroundMethodInfluentialSelf-citationHigel, F., Seidl, A., Sörgel, F., & Friess, W. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.005 · Cited by 360
Bioprocessing in the Digital Age: The Role of Process Models
Narayanan, H., Luna, M. F., von Stosch, M., Cruz Bournazou, M. N., Polotti, G., Morbidelli, M., Butté, A., & Sokolov, M. (2020) · Biotechnology Journal · doi:10.1002/biot.201900172 · Cited by 247 · cited 1×
“Thus, they have been used in media formulation and building process– product correlations to characterize the biological system [18].”
BackgroundChee Furng Wong, D., Tin Kam Wong, K., Tang Goh, L., Kiat Heng, C., & Gek Sim Yap, M. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20317 · Cited by 231 · cited 1×
“The limitation of glucose, glutamine [10], galactose [11], manganese [12,13], uridine, ManNAc and sialic”
Backgrounddel Val, I. J., Kontoravdi, C., & Nagy, J. M. (2010) · Biotechnology Progress · doi:10.1002/btpr.470 · Cited by 139
Jimenez del Val, I., Nagy, J. M., & Kontoravdi, C. (2011) · Biotechnology Progress · doi:10.1002/btpr.688 · Cited by 135
Galactosylation variations in marketed therapeutic antibodies
Raju, T. S., & Jordan, R. E. (2012) · mAbs · doi:10.4161/mabs.19868 · Cited by 125 · cited 1×
“The limitation of glucose, glutamine [10], galactose [11], manganese [12,13], uridine, ManNAc and sialic”
BackgroundImpact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells
Ehret, J., Zimmermann, M., Eichhorn, T., & Zimmer, A. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26904 · Cited by 113
Application of Gaussian processes for black-box modelling of biosystems
Ažman, K., & Kocijan, J. (2007) · ISA Transactions · doi:10.1016/j.isatra.2007.04.001 · Cited by 109 · cited 2×
“The predictio s from day 1 and day 5 are all tested in this study, and the mean relative squared errors (MRSE) [38] are compared in Table 3.”
Method
Cited by
Bioprocess systems analysis, modeling, estimation, and control
Luo, Y., Kurian, V., & Ogunnaike, B. A. (2021) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2021.100705 · Cited by 81
Antonakoudis, A., Strain, B., Barbosa, R., Jimenez del Val, I., & Kontoravdi, C. (2021) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2021.107471 · Cited by 42
Ding, C., & Ierapetritou, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121161 · Cited by 41
Self-citationGaddem, M. R., Kim, J., Matsunami, K., Hayashi, Y., Badr, S., & Sugiyama, H. (2024) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2024.101019 · Cited by 41
Optimization of key energy and performance metrics for drug product manufacturing
Chen, Y., Kotamarthy, L., Dan, A., Sampat, C., Bhalode, P., Singh, R., Glasser, B. J., Ramachnadran, R., & Ierapetritou, M. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122487 · Cited by 36
Self-citationReddy, J. V., Raudenbush, K., Papoutsakis, E. T., & Ierapetritou, M. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108179 · Cited by 37
Self-citationA model-based approach towards accelerated process development: A case study on chromatography
Sachio, S., Kontoravdi, C., & Papathanasiou, M. M. (2023) · Chemical Engineering Research and Design · doi:10.1016/j.cherd.2023.08.016 · Cited by 30
“[38], Ding and Ierapetritou [39], Yang and Ierapetritou [40] Design space identification following optimization approaches Zhao, et al.”
MethodDing, C., Gerberich, C., & Ierapetritou, M. (2023) · Journal of Chromatography A · doi:10.1016/j.chroma.2023.464113 · Cited by 24
Self-citationMechanistic and data-driven modeling of protein glycosylation
Shek, C. F., Kotidis, P., & Betenbaugh, M. J. (2021) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2021.100690 · Cited by 26
Dan, A., Liu, B., Patil, U., Manuraj, B. N. M., Gandhi, R., Buchel, J., Chundawat, S. P. S., Guo, W., & Ramachandran, R. (2025) · Control Engineering Practice · doi:10.1016/j.conengprac.2024.106198 · Cited by 20
Ding, C., & Ierapetritou, M. (2024) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2024.108642 · Cited by 19
Self-citationHayashi, Y., Kino‐oka, M., & Sugiyama, H. (2021) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2021.107566 · Cited by 18
Malinov, N. G., Raudenbush, K., Ding, C., Reddy, J. V., & Ierapetritou, M. (2024) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2024.101044 · Cited by 10
Self-citationReddy, J. V., Leibiger, T. M., Singh, S. K., Lee, K. H., Papoutsakis, E. T., & Ierapetritou, M. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28916 · Cited by 9
“…space for critical process parameters, determine optimal media feeding schedules, and understanding the relationship between disease and protein glycosylation (Flevaris and Kontoravdi 2022; Kotidis et al. 2019; Krambeck et al. 2017; Malinov et al. 2024; Sou et al. 2017; Yang and Ierapetritou 2021).”
Self-citationBravo-Venegas, J., Rodriguez-Siza, J., Vergara, M., Torres, M., Dickson, A., Toledo, J. R., Molina, M. C., Hermoso, M. A., Berríos, J., & Altamirano, C. (2026) · mAbs · doi:10.1080/19420862.2026.2643039 · Cited by 6
“38,40,42 At the same time, it also slows secretion of endogenous proteins other than the recombinant mAb, 67 possibly reducing competition for cellular resources.”
Technoeconomic comparison of optimised bioreactor-filtration systems for mAb production
Jones, W., & Gerogiorgis, D. I. (2023) · Computers & Chemical Engineering · doi:10.1016/j.compchemeng.2023.108438 · Cited by 6
Probabilistic Design Space Identification for Upstream Bioprocesses under Limited Data Availability�
Chiplunkar, R., Pauzi, S. M., Sachio, S., Papathanasiou, M. M., & Kontoravdi, C. (2025) · Systems and Control Transactions · doi:10.69997/sct.166359 · Cited by 4
Pranomphon, R., Gialamoidou, S., Yamabhai, M., del Val, I. J., & Sharfstein, S. T. (2025) · Biotechnology Journal · doi:10.1002/biot.70143 · Cited by 4
PSE Tools and Challenges in the Development of Advanced Pharmaceutical Manufacturing
Chen, Y., Bhalode, P., Yang, O., & Ierapetritou, M. (2022) · Computer-aided chemical engineering/Computer aided chemical engineering · doi:10.1016/b978-0-323-85159-6.50003-8 · Cited by 3
Self-citationTowards the Development of Digital Twin for Pharmaceutical Manufacturing
Raudenbush, K., Malinov, N. G., Reddy, J. V., Ding, C., Tian, H., & Ierapetritou, M. (2024) · Systems and Control Transactions · doi:10.69997/sct.135296 · Cited by 4
Self-citationAdaptive framework for data-driven probabilistic design space identification
Chiplunkar, R., Galeazzi, A., Papathanasiou, M. M., & Kontoravdi, C. (2026) · Chemical Engineering Science · doi:10.1016/j.ces.2026.124255 · Cited by 1
Application of PSE Methods on Monoclonal Antibody Productivity Improvement and Quality Control
Yang, O., & Ierapetritou, M. (2022) · Computer-aided chemical engineering/Computer aided chemical engineering · doi:10.1016/b978-0-323-85159-6.50369-9 · Cited by 2
Self-citationGyorgypal, A., Potter, O. G., Chaturvedi, A., Powers, D. N., & Chundawat, S. P. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.22.521623 · Cited by 2
Towards "tighter" titer: model predictive control in fed-batch bioreactors
Νικολακοπούλου, Α., Luo, Y., & Hatzenbeller, Z. (2025) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc63710.2025.11107677 · Cited by 1
“…& Analytics, Collegeville, PA, USA, anastasianikolako@gmail.com 2 GSK, Biopharm Drug Substance Development, Upper Merior, PA, USA, yu.8.luo@gsk.com , zach.a.hatzenbeller@gsk.com wave of model-based strategies in an attempt to improve and control the process yield and product quality [3].”
Doyle, K., Yang, O., Colarusso, T., Bano, G., Glennon, B., & del Val, I. J. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70339 · Cited by 1
Self-citationData-Driven Approach for Bioreactor Monitoring and Prediction in Monoclonal Antibody Production
Kubra, K., & Shaik, M. A. (2026) · ACS Omega · doi:10.1021/acsomega.6c04405
Metadata
- Authors
- Yang, O., & Ierapetritou, M.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- University of Delaware (US)
- Corresponding author
- Ierapetritou, Marianthi
- Venue
- Processes
- Publisher
- MDPI AG
- Published
- 2021-02-09
- Volume
- 9
- Issue
- 2
- Pages
- 324
- ISSN
- 2227-9717 (ISSN-L)
- OpenAlex
- W3126869566
- Cited by
- 26
- References
- 36
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 5
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Processes (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Food and Drug Administration (DHHS-FDA-R01FD006588)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- monoclonal antibody production, quality by design, mechanistic modeling, glycosylation, protein productivity, design space, feasibility study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.